{"nct_id":"NCT03447249","title":"A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)","status":"COMPLETED","status_verified_date":"2020-03","start_date":"2018-03-07","start_date_type":"ACTUAL","primary_completion_date":"2019-02-05","primary_completion_date_type":"ACTUAL","completion_date":"2019-02-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["VRTX"]}